Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 2.21 -0.09 (3.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $ | |||
| Open | $2.33 | 52 Week Low | $ | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $ | |||
| Volume | 654,661 | |||||
| (NASDAQ: NTRA) | Delayed: 404.90 +0.95 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $403.95 | 52 Week High | $13.80 | |||
| Open | $404.71 | 52 Week Low | $6.52 | |||
| Day High | $407.88 | P/E | N/A | |||
| Day Low | $400.00 | EPS | $0.00 | |||
| Volume | 2,049,390 | |||||



